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Background : Malignant mesothelioma (MM) is a rare malignant neoplasm occurring in pleu-
ra, pericardium, and peritoneum. The differential diagnosis between MM and metastatic ade-
nocarcinoma (MA) causes diagnostic, staging, and therapeutic dilemmas. Herein, we investi-
gated characteristic cytologic features of MM. Methods : Cytologic specimens of MM (n=10),
MA (n=25), and reactive mesothelial hyperplasia (n=10) were retrieved and reviewed from
archival materials in the Department of Pathology, Seoul National University Bundang Hospi-
tal from May 2003 to July 2008. Results : MM showed tumor cell clusters and singly scat-
tered malignant tumor cells forming single cell populations with sparse reactive benign mesothe-
lial cells. In contrast, MA showed distinct two cell populations of tumor cell clusters and scat-
tered reactive mesothelial cells. Furthermore, MM frequently exhibited a  characteristic long
chain-like arrangement (hand-in-hand appearance) and intercellular windows, which were
rarely evident in MA. Variable nuclear size, relatively consistent nuclear-cytoplasmic ratio, bi-
or multi-nucleation, and lacy cytoplasmic borders were also frequently observed in MM. Con-
clusions : Differential diagnosis of MM from MA in body fluids is possible based on meticu-
lous examination of certain cytologic parameters, which could have significant implications in
staging and treatment.
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Malignant Mesothelioma in Body Fluids
- with Special Reference to Differential Diagnosis from
Metastatic Adenocarcinoma -
Malignant mesothelioma (MM) is a rare malignant tumor
occurring in pleura, peritoneum, and pericardium. Similarities
with metastatic adenocarcinoma (MA) can occasionally hamper
differential diagnosis as well as cause diagnostic, staging and
therapeutic dilemmas in clinical management. Since the two
tumors have different origins, primary sites, staging systems and
therapeutic options, the diagnosis of body fluid involvement
would differentially affect therapeutic strategies or prognosis of
patients. From the view point of pathologists, the two tumors are
occasionally confused even in biopsy material, requiring ancillary
tests such as immunohistochemistry and electron microscopy,
which add to the time and cost of diagnosis.1 A number of tri-
als have sought to differentiate between MM and MA on histo-
logic sections using panels of multiple immunohistochemical
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markers and complex statistical analysis,1-3 exemplifying the
difficulty in differentiating MM from MA. Sometimes, even
histology supported by immunohistochemistry may not con-
clusively distinguish the two tumors. In contrast, body fluid
cytology is superior to histology in observing delicate cytomor-
phologic details, and represents a less invasive, inexpensive,
simple, and quick means of diagnosis. Body fluid is often the
first and sometimes the only specimen submitted to pathologists,
which requires more attention to cytologic diagnosis. There-
fore, precise distinction between MM and MA on the basis of
body fluid cytology according to reasonable cytomorphologic
criteria is not only important and useful, but also cost- and time-
effective. The reality of practical pathologic examinations includes
occasional cases where careful morphologic examination with
appropriate parameters or methods is more useful to reach the
conclusion, avoiding unnecessary procedures to patients.4 In that
context, the aim of this study was to define characteristic cyto-
logic features of MM distinct from those of MA, and investigate
the practical usefulness of the cytologic parameters.
MATERIALS AND METHODS
Patients and samples
Cytologic specimens of 10 MM, 25 MA, and 10 reactive
mesothelial hyperplasias were retrieved from the archival mate-
rials in the Department of Pathology, Seoul National Universi-
ty Bundang Hospital from May 2003 to July 2008. The diag-
nosis of MM was supplemented by immunostaining on histo-
logic sections or cell blocks in nine cases, or by histology alone
in one case. The specimens were from eight male and two female
patients diagnosed with MM (39-82-years-of-age, mean age
64.6 years; Table 1). Body fluid samples were pleural fluid in
seven cases, peritoneal fluid in two cases, and pericardial fluid
in one case. The diagnosis of MM was based on the criteria in
the World Health Organization classification of lung and pleu-
ral tumors.5 Primary sites of 25 MA were the lung in 12 cases,
stomach in seven cases, bile duct in two cases, and one case each
from colon, breast, pancreas, and ovary. All 25 cases were pleural
fluids obtained from nine males and 16 females (28-79-years-
of-age, mean age 55.7 years). All 10 reactive mesothelial hyper-
plasia samples were pleural fluids. 
Cytology interpretation and statistical analysis
Papanicolaou and Diff-Quik staining was performed after
cytocentrifugation of all body fluid specimens. Cytologic evalu-
ation was performed with special reference to several cytomor-
phologic criteria including: 1) cellular composition containing
scattered and clustered atypical cells, 2) long chain-like arrange-
ment, 3) intercellular window formation, 4) fuzzy margin with
microvilli, 5) intracytoplasmic vacuole formation, 6) infiltra-
tion of inflammatory cells, and 7) other conventional cytologic
features described for MM or MA. Cytology slides were blindly












1 M 63 Pleura No No Yes NA CK+, VT+, HBME-1+, Calretinin f+, CEA f+, CK5/6+
2 F 59 Peritoneum Yes Yes No NA CK+, VT+, Calretinin+, HBME-1+, CEA-, LeuM-1-
3 M 39 Pericardium Yes Yes No Biphasic CK+, VT+, D2-40+, Calretinin+, CK5/6 f+
4 M 71 Pleura Yes Yes Yes NA CK+, VT+, Calretinin+, D2-40-, TTF-1-, CEA-
5 M 61 Peritoneum Yes Yes No Epithelioid CK5/6+, VT+, Calretinin+, D2-40+, CEA-
6 M 68 Pleura Yes Yes Yes Biphasic CK+, VT+, CK5/6 w+, Calretinin+, D2-40 f+, HBME-1-,
TTF-1 f+, CEA-, LeuM-1-
7 M 68 Pleura Yes Yes Yes Biphasic CK+, VT+, CK5/6+, CEA f+, Calretinin+, HBME-1+
8 M 59 Pleura Yes No No Well NA
differentiated
papillary
9 F 82 Pleura No No Yes NA Calretinin+, D2-40+, HBME-1+, CEA-, TTF-1-
10 M 76 Pleura No No Yes Epithelioid Calretinin+, CK5/6+
NA, not analyzable; IHC, immunohistochemistry; ICC, immunocytochemistry; CB, cell block; CK, cytokeratin; VT, vimentin; CEA, carcinoembryonic
antigen; TTF-1, thyroid transcription factor-1; +, positive; -, negative; f+, focal positive; w+, weak positive.
Table 1. Clinical and pathologic features of 10 malignant mesothelioma cases
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cytologic findings were categorized as present, absent, or equiv-
ocal as for the aforementioned specific items. To make the descri-
ptive terms clear and objective, we used the terms, “two-dimen-
sional (2D) cell group” and “three-dimensional (3D) cell group”
instead of “papilla” or “cell ball,” respectively, reflecting only the
presence of 2D and 3D structures, regardless of shape. Moreover,
to reflect the proportion of cell groups, especially in cases hav-
ing both 2D and 3D cell groups, we evaluated the “major com-
ponent” between these groups, which was defined as cell groups
accounting for >50% of observed total cell groups. The cases
where the extent of 2D and 3D cell groups were similar or cases
where cell group formation was poor and consisted mainly of
scattered tumor cells were categorized as equivocal. Histology
and immunostaining of cell block or histologic sections were
compared to cytologic features of body fluid samples. For sta-
tistical analysis, Pearson’s chi-square test was done using SAS
version 8.01 (SAS Institute, Cary, NC, USA) for a specific find-
ing in MA and MM, regarding a p-value <0.05 as significant.
Although the same cytologic findings used in differentiation
between MM and MA were applied to reactive mesothelial hyper-
plasia in Table 2, the degree of atypism was not obviously relat-
ed to the malignant level of MM or MA. Reactive mesothelial
hyperplasia was not confused with MM or MA in most cases, so
statistical analysis was performed only between MM and MA.
RESULTS
Table 1 shows profiles of 10 MM cases diagnosed on the bases
of cytology, histology and immunostaining. Histologic types were
biphasic type containing epithelioid component (n=3), epithe-
lioid type (n=2), well-differentiated papillary type (n=1), and
‘not analyzable’ (n=4). The latter lacked a sufficient amount of
biopsy material or contained severe cautery artifact, which pre-
cluded assignment of a definite histologic types, but at least focal-
ly included an epithelioid component. Although some cases
showed partially overlapping, focal, weak, lacking, or aberrant
immunostaining findings in the differentiation of MM and MA,
the collective interpretation of cytology, histology, and multi-
ple immunostaining allowed an unequivocal diagnosis.
Next, we compared MM and MA with all the possible cyto-
morphologic parameters and examined whether each of the pa-
rameters were really useful for differentiation on cytologic prepa-
ration alone. As compared with MA, MM showed characteris-
tic morphological features in terms of cellular arrangement and
individual cell appearance (Fig. 1A-H, Table 2). Regarding the
Cytologic features of atypical cells p-valuea
- + - + - +
MM, N=10 MA, N=25 RMH, N=10
Presence of singly scattered atypical cells 1 0 9 11 4 10 6 2 2 0.0057b
Distinct two cell population 0 4 6 14 9 2 10 0 0 <0.0001b
(single cells vs clusters)
Presence of 2D cell group 1 1 8 4 5 16 5 0 5 0.5945
Presence of 3D cell group 4 1 5 5 6 14 8 2 0 0.2625
Major componentc (2D vs 3D) 2D:6 2 3D:2 2D:10 3 3D:12 2D:5 5 3D:0 0.0822
Border scalloping of cell clusters 2 1 7 5 4 16 7 1 2 0.7004
Long chain appearance of atypical cells 4 0 6 22 3 0 8 2 0 <0.0001b
Intercellular window 1 1 8 18 4 3 4 0 6 <0.0001b
Marked variability of nuclear size 0 1 9 11 1 13 10 0 0 0.0011b
Relatively consistent nuclear-cytoplasmic ratio 0 0 10 15 3 7 0 0 10 <0.0001b
Bi- or multi-nucleated atypical cells 0 0 10 11 3 11 3 0 7 0.0018b
Prominent nucleoli with vesicular chromatin 1 0 9 6 2 17 2 0 8 0.2038
Cytoplasmic vacuoles 0 2 8 8 2 15 4 0 6 0.0088b
Cell-in-cell appearance 3 3 4 16 1 8 10 0 0 0.0080b
Fuzzy border with microvilli 0 0 10 20 3 2 1 2 7 <0.0001b
Inflammatory cells outnumbering atypical cells 2 2 6 14 2 9 4 0 6 0.0055b
Psammoma body 10 0 0 24 0 1 10 0 0 1.000
aindicates p value by Pearson’s 2-test in MM and MA, and bindicates p<0.05; cmeans cell groups accounting for more than 50% of total observed
atypical cell groups.
MM, malignant mesothelioma; MA, metastatic adenocarcinoma; RMH, reactive mesothelial hyperplasia; -, absent; , equivocal; +, present; 2D, two
dimensional; 3D, three dimensional.
Table 2. Comparison of cytologic features between malignant mesothelioma, metastatic adenocarcinoma, and reactive mesothelial
hyperplasia
Malignant Mesothelioma in Body Fluids  461
cellular pattern, MM frequently (p=0.0057) showed singly scat-
tered tumor cells (Fig. 1A) and frequently (p<0.0001) displayed
biphasic tumor cell composition (i.e., morphologically identi-
cal malignant cells from both tumor cell clusters and adjacent
scattered tumor cells; “one cell population of scattered and clus-
ters of atypical cells” with rare intermixed reactive benign meso-
Fig. 1. Common cytologic features of malignant mesothelioma (Papanicolaou stain). (A) Singly scattered and clusters of tumor cells form
one cell population are observed. (B) The tumor cells arrange in a long chain-like pattern with a “hand-in-hand” appearance. (C) Intercel-
lular windows are observed in two-dimensional tumor cell sheets. (D) Variable sized tumor cells present a monotonous appearance with
relatively consistent nuclear-cytoplasmic ratio. (E) Multinucleated cells with large nucleoli are commonly observed. (F) The cytoplasm of
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Fig. 1. (Continued from the previous page) (G) The tumor cells are overlapped forming a cell-in-cell appearance. (H) The tumor cell
groups form papillary clusters with scalloped borders.
G H
Fig. 2. Comparison of representative patterns of malignant mesothelioma and metastatic adenocarcinoma. (A) Malignant mesothelioma
shows loose or less cohesive cell groups forming irregularly linear arrangement with singly scattered tumor cells of one cell population
(Papanicolaou stain). (B) Metastatic adenocarcinoma cell clusters are surrounded by reactive mesothelial cells, forming two cell popula-
tions (Papanicolaou stain). (C) Histologic sections show solid sheets of malignant mesothelioma cells (H&E stain). (D) Immunohisto-
chemistry for calretinin shows focal positivity in malignant mesothelioma. 
A B
C D
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thelial cells) (Fig. 1A). In contrast, MA mainly showed the “dis-
tinct two cell population” composed of overtly malignant tumor
cell clusters and scattered adjacent benign mesothelial cells lack-
ing definite atypia that could be regarded as malignant, each of
which was morphologically different. Furthermore, characteris-
tic long chain-like arrangement (“hand-in-hand appearance”)
(Fig. 1B) and intercellular windows (Fig. 1C) were frequently
observed in MM (p<0.001 in both instances), which were absent
or rare in MA.
Individual tumor cells of MM showed round-to-polygonal
contours with markedly variable nuclear size (Fig. 1D; p=0.0011)
but displayed a relatively consistent nuclear-cytoplasmic ratio
(Fig. 1D; p<0.0001). Bi- or multi-nucleated tumor cells (Fig.
1E; p=0.0018), intracytoplasmic vacuoles (Fig. 1F; p=0.0088),
cell-in-cell appearance (Fig. 1G; p=0.0080), lacy cytoplasmic
borders with microvilli (Fig. 1F; p<0.0001), and inflammatory
cells outnumbering tumor cells (Fig. 1D; p=0.0055) were also
commonly observed in MM.
As conventionally described, 2D and 3D cell groups were
compared between MM and MA. However, both cell groups
were frequently observed in both MM and MA. When the major
component accounting for >50% of observed cell groups was
compared in MM and MA, 2D cell groups tended to be frequent-
ly observed in MM, while 3D cell groups predominated in MA,
although neither reached statistical significance (p=0.0822).
Other cytologic parameters including border scalloping of cell
clusters (Fig. 1H), prominent nucleoli with vesicular chromatin,
and psammoma bodies were not significantly different between
MM and MA (p>0.05). 
Fig. 2A, B depict the distinctive features of MM and MA. The
2D cell group of MM was frequently observed as a loose reticular
pattern, tending toward a linear arrangement or single tumor
Fig. 3. Confusing cytologic features in diagnosis of malignant mesothelioma (Papanicolaou stain). (A) Malignant mesothelioma occasion-
ally shows 3-D cell ball pattern. (B) Metastatic adenocarcinoma shows 2-D cell groups with intercellular window-like spaces. (C) Atypical
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cells, which formed a single cell population with an intercellular
window and relatively conserved nuclear cytoplasmic ratio despite
variable nuclear size (Fig. 2A). In contrast, MA frequently revealed
a distinct two cell population consisting of obvious malignant
cell clusters without intercellular window surrounded by benign
mesothelial cells (Fig. 2B). The diagnosis of MM was supple-
mented with histology and/or immunostaining (Fig. 2C, D).
Among all the examined cytologic parameters, some features
were found to be significantly different, while others did not
reach statistical significance in the distinction of MM and MA.
In particular, some conventionally emphasized cytologic features
were variably overlapped, which might confuse differential diag-
nosis without integrated analysis using the aforementioned cyto-
logic findings. As shown in Fig. 3, 3D cell groups (convention-
al “cell ball formation”) in MM (Fig. 3A), or 2D cell groups with
intercellular window-like spaces in MA (Fig. 3B) were rarely
observed. More frequently, atypical mesothelial cells were likely
to be observed in reactive mesothelial hyperplasia, which lacked
definite cellular atypia and complexity of arrangement (Fig. 3C).
Frequently, 2D cell groups forming papillary clusters with scal-
loped borders were observed in MA (Fig. 3D). 
DISCUSSION
MM is a rare malignant neoplasm accounting for <2% of
malignant tumors and 1.6% of malignant pleural effusions.6,7
It is well-known that MM is related to occupational asbestos
exposure, and its latency period is more than 20 years,7 while
some viral exposure with SV40 has been etiologically suggest-
ed.8 Once this rare tumor occurs in pleura, pericardium, or peri-
toneum, its diagnosis is challenging in many cases since distinc-
tion from other tumors can be onerous.9 In the cases of pleural
or pericardial involvement, MA from lung is the main differen-
tial diagnosis, while peritoneal involvement should be distin-
guished from MA of gynecologic or gastrointestinal origin.10,11
Clinically, body cavity effusions might occasionally be an initial
presentation,12 and body cavity fluid cytology is commonly sub-
mitted without sufficient information of the possibility of other
malignancies, which limits cytologic diagnosis. Nevertheless,
careful cytomorphologic examination has been regarded as a reli-
able and accurate method,13 although overall sensitivity of body
fluid cytology has been variably reported.13,14 The correct detec-
tion of MM is critical in that positive effusion in MM might be
in less advanced stages as compared with MA,7 which would
lead to optimal treatments. 
In the present study, we reviewed 10 MM and 25 MA body
fluid cytology cases supplemented with histology or immunos-
taining, and we characterized cytologic features of MM as com-
pared with MA. Although no single feature could completely
distinguish between MM and MA and some features partially
overlapped, collective consideration of general arrangement
pattern combined by individual cell morphology was useful for
cytological distinction between the two tumors.
Of the aforementioned cytologic features, long chain-like ar-
rangement (hand-in-hand appearance) was uniquely observed
as the powerful cytologic parameter; this pattern is suggestive
of MM.11 It was observed as a linear arrangement of tumor cells
containing 10 or more tumor cells, usually with loose direct
contact with the adjacent tumor cells. However, two adjacent
tumor cells sometimes displayed a short gap of ≤one cell width,
intermixed with those having loose direct contact. This latter
contact was the connection of two adjacent tumor cells with
minimal areas of cytoplasmic surface occasionally showing cyto-
plasmic protrusions or fuzzy microvilli-like borders, reminiscent
of “hand-in-hand” appearance. Each tumor cell that formed a row
in the long chain-like arrangement could show specific cytolog-
ic features such as mitosis, cell-in-cell appearance, cytoplasmic
vacuole, bi-nucleation, and prominent nucleoli. Long chain-like
arrangement was mostly shown with adjacent tumor cell arrange-
ments forming similar structures either in a parallel or non-par-
allel pattern. A parallel pattern was observed as at least several
(in many cases, most) arrangements of tumor cells, which were
arranged mainly in parallel rows (Fig. 1B). In some cases that
displayed the parallel pattern, parallel rows occasionally merged
and were interconnected at some point forming loose sheared
net-like or reticular patterns. A non-parallel pattern was observed
as tumor cell arrangements lacking definite parallel pattern,
evident mostly as linear tumor cell rows attached to the periph-
ery of loose sheared net-like or partly torn reticular 2D structures,
as a possible intermediate becoming long chain-like arrangement
(Fig. 2A). On the assumption that the configuration of MM cell
clusters in cytologic smear reflected a preserved nature of benign
mesothelial cells, which two-dimensionally line and cover body
wall, and the growth pattern of MM in body cavity that might
be modified by shearing forces during cytologic preparation, the
long chain-like arrangement was thought to be the dissolving
form of MM cell clusters modified by shearing forces in cytolog-
ic preparation, producing unique patterns of cellular arrangement
in MM. Although long chain-like pattern was observed in 60%
of MM samples, it was specific to MM, and so provided a use-
ful discriminator. While carcinoma cells exhibit a similar linear
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arrangement, usually observed in aspiration smear preparation
from lobular carcinoma of breast or other carcinomas, the arrange-
ment could be differentiated from the long chain-like arrange-
ment of MM, with a relatively “short chain” -like pattern and
sparse density that hardly exceeded 10 cells and several chains
on a smear slide. A few cases of MA did display a similar linear
arrangement with non-parallel pattern in pleural fluid smears,
which could not meet the length criterion.
Among the total of 10 cases of MM in the present study, the
histologic types were ‘not analyzable’ in four cases, epithelioid
type in two cases, well differentiated papillary type in one case,
and biphasic type containing epithelioid component as a major
component in three cases. The four ‘not analyzable’ cases includ-
ed two cases having only cell block sections and two cases hav-
ing both cell block and biopsy material in which assignment of
the histological type was impeded by the lack of material or
presence of severe cautery artifact. However, the contents of these
four cases in cell block sections or histologic sections showed at
least focally epithelioid features, which suggested the presence
of epithelioid components. Therefore, all MM cases appeared to
mainly contain epithelioid components, and the relationship
between presence of long chain-like arrangement of tumor cells
and histologic types was not significant. 
Another notable differential point is homogeneity of cell pop-
ulation,11 which consists of tumor cell clusters and adjacent singly
scattered cells. Recognition of two cell populations suggested
that the tumors originated from other than the mesothelium,
because singly scattered cells were mainly reactive mesothelial
cells. Interestingly, in cytologic preparations of some MM cases,
2D tumor cell sheets tended to become loose sheets, long chain,
or scattered single tumor cells, as a morphologic continuum,
all of which were composed of one cell population (Fig. 2A).
Other conventionally well-known features also found as use-
ful parameters included intercellular window, markedly variable
nuclear size, relatively consistent nuclear-cytoplasmic ratio, bi-
or multi-nucleated tumor cells, intracytoplasmic vacuole, cell-
in-cell appearance, lacy cytoplasmic borders with microvilli, and
inflammatory cells outnumbering tumor cells. Among them,
intercellular window, relatively consistent nuclear-cytoplasmic
ratio, and lacy border with microvilli were especially useful par-
ameters (p<0.0001). 
In the present study, recognition of two newly described uni-
que cytological patterns was very useful for differentiation of
MM containing mainly epithelioid type and MA. These were
cellular composition consisting of atypical cell groups and adja-
cent scattered cells (one cell pattern in MM vs two cell pattern
in MA), and long chain-like arrangement mainly in MM. Alt-
hough these two features themselves were not fully sufficient
for distinction of MM and MA, the integrated analysis of vari-
ous cytologic characteristics was powerful for differentiation of
MM and MA. For the integrated analysis on the basis of mor-
phology, recognition of specific and easily discernable patterns
is important and can practically be the basis for extension to
other cytologic features. In that context, this study has signifi-
cant implications for not only cytomorphologic basis of “pattern
recognition” but also clinical and therapeutic managements.
There was a well-differentiated papillary mesothelioma
(WDPM) of pleura in our series, which is very rare, especially
in pleura, and which displays an indolent clinical course unlike
conventional MM.15 As compared with the other nine MM
cases, WDPM showed relatively abundant round-shape papil-
lary cell groups covering large portions of the slide surface, with
a less pleomorphic nuclear feature. Although WDPM also tend-
ed to form a one cell pattern like other MM cases, its relatively
bland-looking scattered tumor cells were not strikingly distinct
from intermixed reactive mesothelial cells, which required care-
ful interpretation in recognizing “patterns.”
Immunostaining on histologic sections or cell block general-
ly distinguishes between MM and MA, especially with pancy-
tokeratin, vimentin, cytokeratin 5/6, calretinin, D2-40, TTF-1
and CEA.11,16,17 However, not infrequently, the immunostain-
ing pattern can overlap between MM and MA, or is weak, focal,
aberrant or lacking, which can confuse differential diagnosis
without cytomorphologic consideration. Immunostaining results
using specific antibody vary widely in lung cancer according to
different antibody clones,18 which requires more cautious inter-
pretation.
In summary, differential diagnosis of MM from MA in body
fluid was possible based on certain cytologic parameters and can
be even more helpful than histopathologic diagnosis when a
scant amount of biopsy material is available and/or in the pres-
ence of cautery artifact, which can complicate immunoprofiling.
Therefore, meticulous examination using the panel of cytologic
parameters elucidated in this study would lead to early and accu-
rate diagnosis of MM, avoiding misdiagnosis and inappropriate
invasive procedures. 
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